ASCENDIS PHARMA A/S - ADR (ASND)

US04351P1012 - ADR

151.17  +2.73 (+1.84%)

After market: 151.17 0 (0%)

Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to ASND. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 175.64. This target is 16.19% above the current price.
ASND was analyzed by 20 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about ASND.
In the previous month the buy percentage consensus was at a similar level.
ASND was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 151.17117.16173.93175.64236.25 - -22.50% 15.06% 16.19% 56.28%
Up and Down Grades
Date Firm Action Rating
2024-03-15 Wells Fargo Maintains Overweight -> Overweight
2024-02-08 Wedbush Maintains Outperform -> Outperform
2024-02-08 Citigroup Maintains Buy -> Buy
2024-02-06 Cantor Fitzgerald Maintains Overweight -> Overweight
2023-12-20 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-12-20 Wedbush Maintains Outperform -> Outperform
2023-12-20 Jefferies Initiate Buy
2023-12-19 Wells Fargo Maintains Overweight -> Overweight
2023-11-09 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-11-08 Wedbush Reiterate Outperform -> Outperform
2023-09-15 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-09-07 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-09-06 Wedbush Maintains Outperform -> Outperform
2023-09-06 Wells Fargo Maintains Overweight -> Overweight
2023-09-06 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-08-07 Morgan Stanley Reiterate Equal-Weight -> Equal-Weight
2023-08-01 Morgan Stanley Reiterate Equal-Weight -> Equal-Weight
2023-07-31 Morgan Stanley Reiterate Equal-Weight -> Equal-Weight
2023-07-24 Morgan Stanley Reiterate Equal-Weight -> Equal-Weight
2023-07-17 Morgan Stanley Reiterate Equal-Weight -> Equal-Weight
2023-06-26 Morgan Stanley Reiterate Equal-Weight -> Equal-Weight
2023-06-20 Morgan Stanley Reiterate Equal-Weight -> Equal-Weight
2023-06-12 Morgan Stanley Reiterate Equal-Weight -> Equal-Weight
2023-06-07 Wedbush Reiterate Outperform -> Outperform
2023-06-02 Wedbush Maintains Outperform -> Outperform
2023-06-01 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-05-08 Wedbush Maintains Outperform
2023-04-28 Cantor Fitzgerald Maintains Overweight
2023-04-28 Credit Suisse Maintains Neutral
2023-04-28 Morgan Stanley Maintains Equal-Weight